Natera Inc
NASDAQ:NTRA 1:48:24 PM EDT
| Market Cap (Intraday) | 22.11B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $166.92 |
| 50-Day MA | $159.10 |
| 200-Day MA | $151.78 |
Natera Inc Stock, NASDAQ:NTRA
Building A, 13011 McCallen Pass, Suite 100, Austin, Texas 78753
United States of America
Phone: +1.650.980.9190
Number of Employees: 4434
Description
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in Austin, TX.